Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon

Life Sciences

Volumn 72, Issue 17, 2003, Pages 1909-1918

  Petzelt, Christian ^a   Blom, Per ^b   Schmehl, Wolfgang ^b   Müller, Jana ^a   Kox, Wolfgang J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b AGA Linde Healthcare   (Sweden)

Author keywords

Calcium; Glutamate; Hypoxia; Neuroprotection; Xenon

Indexed keywords

CALCIUM; CALCIUM CHELATING AGENT; DIZOCILPINE; GLUTAMIC ACID; HELIUM; INERT GAS; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; NITROGEN; NITROUS OXIDE; XENON;

ANIMAL CELL; ARTICLE; ATMOSPHERE; BRAIN CELL; BRAIN HYPOXIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; EMBRYO CELL; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT;

EID: 0037436734     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02439-6     Document Type: Article

References (38)

1. Aronowski J., Waxham M.N., Grotta J.C. Neuronal protection and preservation of calcium-calmodulin-dependent protein kinase II and protein kinase C by dextrorphan treatment in global ischemia. Journal of Cerebral Blood Flow Metabolism. 13:1993;550-557.
2. Buchan A.M., Pulsinelli W.A. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischaemia. Journal of Neuroscience. 10:1990;311-316.
3. Buchan A.M., Slivka A., Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Research. 574:1992;171-177.
4. Choi D.W., Maulucci-Gedde M., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. Journal of Neuroscience. 7:1987;357-368.
5. Choi D.W., Koh J.Y., Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. Journal of Neuroscience. 8:1988;185-196.
6. Cullen S.C., Gross E.G. The anaesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science. 113:1951;580-582.
7. De Sousa S.L.M., Dickinson R., Lieb W.E., Franks N.P. Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology. 92:2000;1055-1066.
8. Dingley J., Ivanova-Stoilova T.M., Grundler S., Wall T. Xenon: recent developments. Anaesthesia. 54:1999;335-346.
9. Franks N.P., Dickinson R., De Sousa S.L.M., Hall A.C., Lieb R. How does xenon produce anaesthesia? Nature. 396:1998;324.
10. 2+/calmodulin-regulated protein phosphatase, calcineurin. Neuroscience. 62:1994;698-705.
11. Hajomohammaadreza I.A., Probert A.W., Cougenhour L.L. A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. Journal of Neuroscience. 15:1995;4093-4101.
12. 2+/calmodulin-dependent protein kinases. Annual Reviews of Biochemistry. 61:1992;559-601.
13. Hashimoto T., Kawamata T., Saito N., Sasaki M., Nakai M., Niu S., Taniguchi T., Terashima A., Yasuda M., Maeda K., Tanaka C. Isoform-specific redistribution of calcineurin A alpha and A beta in the hippocampal CA1 region of gerbils after transient ischemia. Journal of Neurochemistry. 70:1998;1289-1298.
14. Hoyt K.R., Reynolds I.J., Hastings T.G. Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: Interactions with and differences from glutamate-induced cell death. Experimental Neurolology. 143:1996;269-281.
15. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. Journal of Neuroscience Methods. 20:1987;83-90.
16. 2+/calmodulin kinase II translocates in a hippocampal slice model of ischemia. Journal of Neurochemistry. 64:1995;2147-2156.
17. Lengyel I., Fieuw-Makaroff S., Hall A.L., Sim A.T.R., Rostas J.A.P., Dunkley P.R. Modulation of the phosporylation and activity of calcium/calmodulin-dependent protein kinase II by zinc. Journal of Neurochemistry. 75:2000;594-605.
18. Mennerick S., Jevtovic-Todorovic V., Todorovic S.M., Shen W., Olney J.W., Zorumski C.F. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. Journal of Neuroscience. 18:1998;9716-9726.
19. Meshul C.K., Tan S.E. Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity. Synapse. 18:1994;205-217.
20. 2+/calmodulin-dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia. Journal of Neurochemistry. 58:1992;1798-1809.
21. Morioka M., Hamada J.I., Ushio Y., Miyamoto E. Potential role of calcineurin for brain ischemia and traumatic injury. Progress in Neurobiology. 58:1999;1-30.
22. Mullany P., Conolly S., Lynch M.A. Ageing is associated with changes in glutamate release, protein tyrosine kinase and Ca2+/calmodulin-dependent protein kinase II in rat hippocampus. European Journal of Pharmacology. 309:1996;311-315.
23. Mytilineou C., Han S.K., Cohen G. Toxic and protective effects of L-dopa on mesencephalic cell cultures. Journal of Neurochemistry. 61:1993;1470-1478.
24. Nichols R.A., Sihra T.S., Czernik A.J., Nairn A.C., Greengard P. Calcium/calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes. Nature. 343:1990;647-651.
25. Nichols R.A., Suplick G.R., Brown J.M. Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. Journal of Biological Chemisty. 269:1994;23817-23823.
26. Obrenovitch T.P., Urenjak J., Zilkha E., Jay T.M. Excitotoxicity in neurological disorders - the glutamate paradox. International Journal of Developmental Neuroscience. 18:2000;281-287.
27. 2+-regulated transitions in the cell cycle of human endothelial cells. European Journal of Physiology. 437:1999;737-744.
28. Petzelt C., Taschenberger G., Schmehl W., Hafner M., Kox W.J. Xenon induces metaphase arrest in rat astrocytes. Life Sciences. 65:1999;901-913.
29. 2+-calmodulin-activated kinase in the control of metaphase-anaphase transition in human cells. Cell Biology International. 25:2001;403-409.
30. Saluja I., O'Regan M.H., Song D., Phillis J.W. Activation of cPLA2, PKC, and ERKs in the rat cerebral cortex during ischemia/reperfusion. Neurochemical Research. 24:1999;669-677.
31. Shira T.S., Pearson H.A. Ca/calmodulin-dependent kinase II inhibitor KN62 attenuates glutamate release by inhibiting voltage-dependent Ca(2+)-channels. Neuropharmacology. 34:1995;731-741.
32. Shira T.S., Nairn A.C., Kloppenburg P., Pouzat C. A role for calcineurin (protein phosphatase-2B) in the regulation of glutamate release. Biochemical Biophysical Research Communications. 212:1995;609-615.
33. 2+/calmodulin-dependent protein kinase II. Journal of Biological Chemistry. 276:2001;3719-3722.
34. Turnell D.C., Cooper J.D.H. Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clinical Chemistry. 28:1982;527-531.
35. Vornov J.J., Tasker R.C., Coyle J.T. Delayed protection by MK-801 and tetrodotoxin in a rat organotypical hippocampal culture model of ischemia. Stroke. 25:1994;457-465.
36. Wilhelm S.W., Daqing M., Maze M., Franks N.P. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology. 96:2002;1485-1491.
37. Yamakura T., Harris R.A. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol Anesthesiology. 93:2000;1095-1101.
38. 2+ release from mitochondria. Journal of Neuroscience. 19:1999;3307-3315.